We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FOSL:NASDAQFossil Group, Inc. Analysis

Data as of 2026-04-04 - not real-time

$4.65

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Fossil Group (FOSL) is trading at $4.65, comfortably above its 20‑day SMA ($4.27) and 50‑day SMA ($4.12), with a bullish MACD histogram (+0.021) and RSI near 60, indicating short‑term momentum is intact. Technical indicators suggest a bullish trend, and the price sits midway between the identified support ($3.77) and resistance ($4.99) levels, leaving room for upside. However, the fundamentals tell a more cautious story: revenue fell 18% YoY, profit margin is negative (-7.8%), and the company posted a Q4 loss of $18.6 million, with trailing EPS of –$1.45. The balance sheet is strained, featuring a debt‑to‑equity ratio of 365% and total debt of $317 million against $102 million of cash, while operating cash flow remains negative. Despite these challenges, free cash flow turned positive ($53.9 million) and the forward EPS projection of $0.095 yields a forward P/E of 48.9, implying the market expects a turnaround. The DCF‑derived fair value of $8.78 translates to a ~50% upside from current levels, and analysts have issued a “strong buy” with a median target of $7, indicating optimism about margin improvements noted in recent earnings calls.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical setup with price above key moving averages
  • Recent earnings miss and negative profitability
  • High beta and decreasing volume indicating volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Potential margin expansion highlighted in earnings call
  • DCF upside of ~50% and analyst “strong buy” consensus
  • Improving free cash flow despite operating cash deficits

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Elevated leverage and negative ROE raise structural concerns
  • Consumer cyclical exposure makes earnings sensitive to economic cycles
  • Long‑term valuation still attractive relative to fair value estimate

Key Metrics & Analysis

Financial Health

Revenue Growth-18.00%
Profit Margin-7.80%
P/E Ratio48.9
ROE-69.65%
ROA1.98%
Debt/Equity365.36
P/B Ratio2.5
Op. Cash Flow$-57897000
Free Cash Flow$53.9M

Technical Analysis

TrendBullish
RSI59.9
Support$3.77
Resistance$4.99
MA 20$4.27
MA 50$4.12
MA 200$3.00
MACDBullish
VolumeDecreasing
Fear & Greed Index78.8

Valuation

Fair Value$8.78
Target Price$7.00
Upside/Downside50.54%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.72
Volatility77.70%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.